Skip to content
Life Sciences Series B Founded 2011

LensGen

Developer of Intraocular lens for presbyopia correction

📍 Irvine, United States · Ophthalmology

Funding snapshot

Last roundSeries B
Amount$10M
Date20 August 2020

About

Developer of Intraocular lens for presbyopia correction. It has developed a biomimetic device with the inherent ability to change shape like the natural human lens. This technology would be used in the surgical treatment of presbyopia and cataracts.

Latest news

No articles yet.

Raising like LensGen?

Analyze your pitch deck before your next raise.

Analyze My Deck →